Minimally invasive surgery for interval cytoreduction in advanced ovarian cancer has been associated with improved perioperative outcomes without compromising survival; however, comparative data between robotic and laparoscopic approaches remain limited.We conducted a retrospective cohort study using the National Cancer Database, including patients with stage III high-grade serous ovarian cancer who
Levin et al. (2026) studied this question.